Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Higher dose / Wegovy HD (approved March 2026): The 7.2 mg injection, which demonstrated approximately 21% average weight loss over 72 weeks in the STEP UP trial, with over 90% of participants achieving at least 5% weight loss and about a third losing 25% or more
Sheryl Ross (Dr.Sherry), our Chief Medical Officer of Womens Health here at QuickMD
Tackle the biggest challenges of weight loss with a proven formula and regimen that fits into your busy schedule
Combination therapies and lifestyle interventions, including diet and exercise, remain integral to comprehensive obesity management
Semaglutide is a GLP-1 receptor agonist, while tirzepatide combines GIP and GLP-1 receptor agonism, producing stronger effects on satiety and weight loss
You don't see this often, but the LiPo pack pictured above actually indicates three different discharge C rates, along with the sustained discharge current underneath each one
US$ 24.90
US$ 27.06
US$ 27.73
US$ 29.75
US$ 19.99
US$ 22.78
US$ 24.43
